Intra-cellular therapies announces appointment of sanjeev narula as chief financial officer

New york, aug. 07, 2024 (globe newswire) -- intra-cellular therapies, inc. (nasdaq: itci), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (cns) disorders, today announced that sanjeev narula will join the company on august 12, 2024 and will serve as executive vice president, chief financial officer. mr. narula will report to dr. sharon mates, itci's chairman and chief executive officer. lawrence hineline, who currently serves as chief financial officer, will retire on the same date but will continue to serve as a consultant to the company for a period of time to ensure a smooth transition.
ITCI Ratings Summary
ITCI Quant Ranking